Portfolio Update

RNS Number : 5227C

Intl. Biotechnology Trust PLC

22 January 2018

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 31 December 2017

Net Assets	£234m
Net Assets per share	624p
Share price	625p
Total value of unquoted investments	£20m
Total number of portfolio companies	92
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Biogen	6.5
Celgene	6.3
Regeneron	4.8
Nektar	4.0
Exelixis	3.9
Vertex	3.6
Adamas	3.4
Acadia	3.2
Genmab	3.0
Gilead	2.8
	-----------
Total	41.5

Geographical Allocation	% NAV
US & Canada	90
Europe & UK	10
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	92
Unquoted	8
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	37
Mid Cap =USD1-10BN	34
Small Cap <USD1BN	29
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	39
Rare diseases	14
CNS	11
Ophthalmology	7
Inflammation	7
Infectious Diseases	5
Metabolic	5
Medtech	3
Other	9
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

22 JANUARY 2018

 

END

 

 

PFUGCGDBCUDBGID